Vascular-Targeted Photodynamic Therapy Using WST 11 in Patients With Localized Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 21 Apr 2016
At a glance
- Drugs Padeliporfin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Steba Biotech
- 07 Jun 2017 Biomarkers information updated
- 05 Jul 2012 Actual end date (1 Jul 2012) added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.